Status:
UNKNOWN
Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Abdominal Aortic Aneurysm,
Small Abdominal Aortic Aneurysm
Eligibility:
All Genders
50-85 years
Phase:
PHASE2
Brief Summary
Aneurysms of the aorta are dilatations of the main artery in the body that distributes blood to organs. Aneurysms expose patients to aortic rupture. The risk of aortic rupture is high for large aneury...
Detailed Description
Abdominal aortic aneurysms (AAAs) expose patients to death caused by aortic rupture. Although screening of AAAs has been shown to decrease AAA-related mortality, translation into medical practice of s...
Eligibility Criteria
Inclusion
- Male patients with asymptomatic AAA ≥ 30 mm, ≤ 49 mm
- Female patients with asymptomatic AAA ≥ 25 mm, ≤ 44 mm
Exclusion
- Common iliac aneurysm \> 25 mm
- Saccular aneurysm of the aorta
- Inflammatory aneurysm
- No signature of informed consent
- Renal dysfunction
- Diabetes
Key Trial Info
Start Date :
December 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2018
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT02225756
Start Date
December 1 2013
End Date
September 1 2018
Last Update
June 3 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henri Mondor Hospital
Créteil, France, 94010